(PTCT) |
| 0 (0%) 10-14 12:08 |
| Open: | |
| High: | |
| Low: | |
| Volume: | 0 |
| Market Cap: | 0(M) |
| PE Ratio: | 0 |
| Exchange: | |
| Industry: | |
| Sector: |
| Technical analysis | ||||
 |
||||
| sell | buy | |||
| Resistance 2: | 68.84 |
| Resistance 1: | 65.20 |
| Pivot price: | 63.22 |
| Support 1: | 59.30 |
| Support 2: | 49.34 |
| 52w High: | |
| 52w Low: |
Financials
| EPS | -0.670 |
| Book Value | -1.990 |
| PEG Ratio | 0.00 |
| Gross Profit | 6.038 |
| Profit Margin (%) | -3.80 |
| Operating Margin (%) | 41.32 |
| Return on Assets (ttm) | 2.5 |
| Return on Equity (ttm) | 0.0 |
Company news
Tue, 13 Oct 2026
PTC Therapeutics (NASDAQ:PTCT) VP Mark Elliott Boulding Sells 192 Shares of Company Stock - MarketBeat
Tue, 13 Oct 2026
After exercising options at $39.42, PTC Therapeutics (PTCT) CLO Boulding sells 192 shares. - Stock Titan
Tue, 13 Oct 2026
(PTCT) and the Role of Price-Sensitive Allocations - Stock Traders Daily
Tue, 13 Oct 2026
PTC Therapeutics (NASDAQ:PTCT) Reaches New 12-Month Low - Time to Sell? - MarketBeat
Tue, 13 Oct 2026
PTCT270115P00100000 Interactive Stock Chart | PTCT Jan 2027 100.000 put Stock - Yahoo Finance
Tue, 13 Oct 2026
PTC Therapeutics, Inc. (PTCT) Stock Forecasts - Yahoo Finance
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
